For too long, the promise of personalized therapies has been tantalizingly close, yet frustratingly out of reach for ...

A Guardian investigation into the U.S. overdose slowdown found that national declines masked sharp local disparities. Here's how the reporting team got the story.

A new tool enables biomedical researchers from around the world to quickly see the connections between lipids and proteins inside cells, thanks to a new initiative led by scientists at Oregon Health & ...

Boston Scientific has received Food and Drug Administration approval for a new pulsed field ablation catheter that is indicated for use as an adjunctive device in a type of ablation that is performed ...

WASHINGTON, Dec. 30, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved NEREUS™ (tradipitant), an oral ...

The FDA said it plans to accept new forms of real-world evidence in product applications, starting with a subset of medical device submissions. The agency said the policy change aims to enable the use ...

This article and associated images are based on a poster originally authored by Frances Hall PhD and Richard Coxon and presented at ELRIG Drug Discovery 2025 in affiliation with Instem. This poster is ...

This is the repository of the jounal paper titled "Integrating Explainable Artificial Intelligence and Carcinogenic Potency Characterization for Safer Nitrosamine Risk Assessment in Drug Synthesis." ...

Theresa Gaffney is the lead Morning Rounds writer and reports on health care, new research, and public policy, with a particular interest in mental health, gender-affirming care, and LGBTQ+ patient ...

WASHINGTON -- Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart attack, dementia and other serious risks, the ...